Murray A. Goldberg - Jan 19, 2023 Form 3 Insider Report for Ayala Pharmaceuticals, Inc. (ADXS)

Role
Director
Signature
/s/ Murray A. Goldberg
Stock symbol
ADXS
Transactions as of
Jan 19, 2023
Transactions value $
$0
Form type
3
Date filed
1/23/2023, 05:15 PM
Previous filing
Jun 15, 2022

No securities are beneficially owned.